Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma.
Chronic pancreatitis
IL-17A
IL-23
Pancreatic ductal adenocarcinoma
Th17 cell
Journal
Immunogenetics
ISSN: 1432-1211
Titre abrégé: Immunogenetics
Pays: United States
ID NLM: 0420404
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
25
04
2023
accepted:
27
07
2023
medline:
22
9
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
T-helper 17 (Th17) cells are a subset of CD4
Identifiants
pubmed: 37540314
doi: 10.1007/s00251-023-01318-4
pii: 10.1007/s00251-023-01318-4
doi:
Substances chimiques
Interleukin-17
0
Nuclear Receptor Subfamily 1, Group F, Member 3
0
Interleukin-23
0
RNA, Messenger
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
433-443Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Bilska M, Pawłowska A, Zakrzewska E, Chudzik A, Suszczyk D, Gogacz M et al (2020) Th17 Cells and IL-17 as novel immune targets in ovarian cancer therapy. J Oncol e8797683. https://doi.org/10.1155/2020/8797683
Cascão R, Moura RA, Perpétuo I, Canhão H, Vieira-Sousa E, Mourão AF et al (2010) Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther 12:R196. https://doi.org/10.1186/ar3168
doi: 10.1186/ar3168
pubmed: 20961415
pmcid: 2991033
Castro G, Liu X, Ngo K, De Leon-Tabaldo A, Zhao S, Luna-Roman R et al (2017) RORγt and RORα signature genes in human Th17 cells. PLoS One 12:e0181868. https://doi.org/10.1371/journal.pone.0181868
Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A et al (2009) The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 119:3011–3023. https://doi.org/10.1172/JCI39065
doi: 10.1172/JCI39065
pubmed: 19741298
pmcid: 2752076
Chen P, Wang M, Li D, Jia Y, He N, Li W et al (2015) The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia. J Immunol Res 2015:16123. https://doi.org/10.1155/2015/416123
Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS et al (2009) Critical regulation of early Th17 cell differentiation by IL-1 signaling. Immunity 30:576–587. https://doi.org/10.1016/j.immuni.2009.02.007
doi: 10.1016/j.immuni.2009.02.007
pubmed: 19362022
pmcid: 2705871
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy - Dimensions. [cited 28 Mar 2021]. Available: https://app.dimensions.ai/details/patent/US-9272057-B2
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul J-L et al (2018) FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med 379:2395–2406. https://doi.org/10.1056/NEJMoa1809775
doi: 10.1056/NEJMoa1809775
pubmed: 30575490
De Simone V, Pallone F, Monteleone G, Stolfi C (2013) Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology 2:e26617. https://doi.org/10.4161/onci.26617
Duan Z, Miller HD, Fu X, Ge D, Jin B, Moustafa AA et al (2019) Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer. Am J Clin Exp Urol 7:249–261
pubmed: 31511831
pmcid: 6734037
Egwuagu CE (2009) STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47:149–156. https://doi.org/10.1016/j.cyto.2009.07.003
doi: 10.1016/j.cyto.2009.07.003
pubmed: 19648026
pmcid: 2733795
Elessawi DF, Alkady MM, Ibrahim IM (2019) Diagnostic and prognostic value of serum IL-23 in colorectal cancer. Arab J Gastroenterol 20:65–68. https://doi.org/10.1016/j.ajg.2019.05.002
doi: 10.1016/j.ajg.2019.05.002
pubmed: 31155425
Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M (2008) Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226:87–102. https://doi.org/10.1111/j.1600-065X.2008.00712.x
doi: 10.1111/j.1600-065X.2008.00712.x
pubmed: 19161418
Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA et al (2010) Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol 185:4063–4071. https://doi.org/10.4049/jimmunol.0902609
doi: 10.4049/jimmunol.0902609
pubmed: 20805420
He S, Fei M, Wu Y, Zheng D, Wan D, Wang L et al (2011) Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients. Int J Mol Sci 12:7424. https://doi.org/10.3390/ijms12117424
doi: 10.3390/ijms12117424
pubmed: 22174607
pmcid: 3233413
Hirota K, Martin B, Veldhoen M (2010) Development, regulation and functional capacities of Th17 cells. Semin Immunopathol 32:3–16. https://doi.org/10.1007/s00281-009-0187-y
doi: 10.1007/s00281-009-0187-y
pubmed: 20107806
Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ et al (2021) Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. Gastroenterology 160:744–754. https://doi.org/10.1053/j.gastro.2020.10.007
doi: 10.1053/j.gastro.2020.10.007
pubmed: 33058868
Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M et al (2011) Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 25:1271–1277. https://doi.org/10.3892/or.2011.1201
doi: 10.3892/or.2011.1201
pubmed: 21369705
Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121–1133. https://doi.org/10.1016/j.cell.2006.07.035
doi: 10.1016/j.cell.2006.07.035
pubmed: 16990136
Karabulut S, Afsar ÇU, Karabulut M, Alış H, Kılıc L, Çikot M et al (2016) Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. J Gastrointest Cancer 47:47–54. https://doi.org/10.1007/s12029-015-9787-z
doi: 10.1007/s12029-015-9787-z
pubmed: 26637231
Karpisheh V, Ahmadi M, Abbaszadeh-Goudarzi K, Mohammadpour Saray M, Barshidi A, Mohammadi H et al (2022) The role of Th17 cells in the pathogenesis and treatment of breast cancer. Cancer Cell Int 22:108. https://doi.org/10.1186/s12935-022-02528-8
doi: 10.1186/s12935-022-02528-8
pubmed: 35248028
pmcid: 8897940
Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517. https://doi.org/10.1146/annurev.immunol.021908.132710
doi: 10.1146/annurev.immunol.021908.132710
pubmed: 19132915
Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141–1149. https://doi.org/10.1182/blood-2009-03-208249
doi: 10.1182/blood-2009-03-208249
pubmed: 19470694
pmcid: 2723011
Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J et al (2007) Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment. J Immunol 178:6730–6733. https://doi.org/10.4049/jimmunol.178.11.6730
doi: 10.4049/jimmunol.178.11.6730
pubmed: 17513719
Lafdil F, Miller AM, Ki SH, Gao B (2010) Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 7:250–254. https://doi.org/10.1038/cmi.2010.5
doi: 10.1038/cmi.2010.5
pubmed: 20305686
pmcid: 3732654
Liao Y, Wang B, Huang Z-L, Shi M, Yu X-J, Zheng L et al (2013) Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study. PLoS One 8:e60444. https://doi.org/10.1371/journal.pone.0060444
Li Y, Jie Y, Wang X, Lu J (2021) Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1/Th2/Th17-related cytokines. BMC Immunol 22:42. https://doi.org/10.1186/s12865-021-00431-x
doi: 10.1186/s12865-021-00431-x
pubmed: 34176464
pmcid: 8237483
Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H et al (2011) IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 407:348–354. https://doi.org/10.1016/j.bbrc.2011.03.021
doi: 10.1016/j.bbrc.2011.03.021
pubmed: 21396350
Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI et al (2015) IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Cancer Res 75:4852–4862. https://doi.org/10.1158/0008-5472.CAN-15-0896
doi: 10.1158/0008-5472.CAN-15-0896
pubmed: 26404002
pmcid: 4651828
Liu X, Jin H, Zhang G, Lin X, Chen C, Sun J et al (2014) Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients. PLoS One 9:e106834. https://doi.org/10.1371/journal.pone.0106834
Lu T, Yu S, Liu Y, Yin C, Ye J, Liu Z et al (2016) Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma. Bertolini F, editor. PLoS One 11:e0148044. https://doi.org/10.1371/journal.pone.0148044
McAllister F, Leach SD (2014) Targeting IL-17 for pancreatic cancer prevention. Oncotarget 5:9530–9531
doi: 10.18632/oncotarget.2618
pubmed: 25393980
pmcid: 4259416
Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A et al (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362–373. https://doi.org/10.1182/blood-2007-11-120998
doi: 10.1182/blood-2007-11-120998
pubmed: 18354038
pmcid: 2442746
Muranski P, Restifo NP (2013) Essentials of Th17 cell commitment and plasticity. Blood 121:2402–2414. https://doi.org/10.1182/blood-2012-09-378653
doi: 10.1182/blood-2012-09-378653
pubmed: 23325835
pmcid: 3612853
Miossec P (2009) IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 11:625–630. https://doi.org/10.1016/j.micinf.2009.04.003
doi: 10.1016/j.micinf.2009.04.003
pubmed: 19371791
Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304:1073–1081. https://doi.org/10.1001/jama.2010.1275
doi: 10.1001/jama.2010.1275
pubmed: 20823433
Parikh PY, Lillemoe KD (2015) Surgical Management of Pancreatic Cancer—Distal Pancreatectomy. Semin Oncol 42:110–122. https://doi.org/10.1053/j.seminoncol.2014.12.010
doi: 10.1053/j.seminoncol.2014.12.010
pubmed: 25726056
Pan B, Shen J, Cao J, Zhou Y, Shang L, Jin S et al (2015) Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep 5:16053. https://doi.org/10.1038/srep16053
doi: 10.1038/srep16053
pubmed: 26524953
pmcid: 4630609
Petermann F, Rothhammer V, Claussen MC, Haas JD, Blanco LR, Heink S et al (2010) γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33:351–363. https://doi.org/10.1016/j.immuni.2010.08.013
doi: 10.1016/j.immuni.2010.08.013
pubmed: 20832339
pmcid: 3008772
Rauen T, Juang Y-T, Hedrich CM, Kis-Toth K, Tsokos GC (2012) A novel isoform of the orphan receptor RORγt suppresses IL-17 production in human T cells. Genes Immun 13:346–350. https://doi.org/10.1038/gene.2011.85
doi: 10.1038/gene.2011.85
pubmed: 22237416
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
doi: 10.3322/caac.21551
pubmed: 30620402
Sfanos KS, Bruno TC, Maris CH, Xu L, Thoburn CJ, DeMarzo AM et al (2008) Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing. ClinCancer Res 14:3254–3261. https://doi.org/10.1158/1078-0432.CCR-07-5164
doi: 10.1158/1078-0432.CCR-07-5164
Song H, Zhang Y (2018) Regulation of pancreatic stellate cell activation by Notch3. BMC Cancer 18:36. https://doi.org/10.1186/s12885-017-3957-2
doi: 10.1186/s12885-017-3957-2
pubmed: 29304760
pmcid: 5756326
Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KHG (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331–341. https://doi.org/10.1016/j.immuni.2009.08.001
doi: 10.1016/j.immuni.2009.08.001
pubmed: 19682929
Tarasiuk A, Mackiewicz T, Małecka-Panas E, Fichna J (2021) Biomarkers for early detection of pancreatic cancer – miRNAs as a potential diagnostic and therapeutic tool? Cancer Biol Ther 22:347–356. https://doi.org/10.1080/15384047.2021.1941584
doi: 10.1080/15384047.2021.1941584
pubmed: 34224317
pmcid: 8386725
Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113. https://doi.org/10.1111/j.1600-065X.2008.00628.x
doi: 10.1111/j.1600-065X.2008.00628.x
pubmed: 18613831
pmcid: 3299089
Valiulyte I, Steponaitis G, Skiriute D, Tamasauskas A, Vaitkiene P (2017) Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma. BMC Med Genet 18:72. https://doi.org/10.1186/s12881-017-0434-3
doi: 10.1186/s12881-017-0434-3
pubmed: 28709401
pmcid: 5513380
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620. https://doi.org/10.1016/S0140-6736(10)62307-0
doi: 10.1016/S0140-6736(10)62307-0
pubmed: 21620466
pmcid: 3062508
Vignali DAA, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13:722–728. https://doi.org/10.1038/ni.2366
doi: 10.1038/ni.2366
pubmed: 22814351
pmcid: 4158817
Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9(6):650–657. https://doi.org/10.1038/ni.1613 . (Epub 2008 May 4. PMID: 18454150)
doi: 10.1038/ni.1613
pubmed: 18454150
Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206:1457–1464. https://doi.org/10.1084/jem.20090207
doi: 10.1084/jem.20090207
pubmed: 19564351
pmcid: 2715087
Wang X, Wang L, Mo Q, Dong Y, Wang G, Ji A (2015) Changes of Th17/Treg cell and related cytokines in pancreatic cancer patients. Int J Clin Exp Pathol 8:5702–5708
pubmed: 26191284
pmcid: 4503155
Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821–852. https://doi.org/10.1146/annurev.immunol.25.022106.141557
doi: 10.1146/annurev.immunol.25.022106.141557
pubmed: 17201677
Wilke CM, Bishop K, Fox D, Zou W (2011) Deciphering the role of Th17 cells in human disease. Trends Immunol 32:603–611. https://doi.org/10.1016/j.it.2011.08.003
doi: 10.1016/j.it.2011.08.003
pubmed: 21958759
pmcid: 3224806
Wu C, Wang S, Wang F, Chen Q, Peng S, Zhang Y et al (2009) Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol 158:199–204. https://doi.org/10.1111/j.1365-2249.2009.04011.x
doi: 10.1111/j.1365-2249.2009.04011.x
pubmed: 19737137
pmcid: 2768809
Wu P, Wu D, Ni C, Ye J, Chen W, Hu G et al (2014) γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40:785–800. https://doi.org/10.1016/j.immuni.2014.03.013
doi: 10.1016/j.immuni.2014.03.013
pubmed: 24816404
pmcid: 4716654
Yang B, Kang H, Fung A, Zhao H, Wang T, Ma D (2014) The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm 2014:623759. https://doi.org/10.1155/2014/623759
Ye Z-J, Zhou Q, Gu Y-Y, Qin S-M, Ma W-L, Xin J-B et al (2010) Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 185:6348–6354. https://doi.org/10.4049/jimmunol.1001728
doi: 10.4049/jimmunol.1001728
pubmed: 20952674
Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma L et al (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374:533–537. https://doi.org/10.1016/j.bbrc.2008.07.060
doi: 10.1016/j.bbrc.2008.07.060
pubmed: 18655770
Zhang J-P, Yan J, Xu J, Pang X-H, Chen M-S, Li L et al (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50:980–989. https://doi.org/10.1016/j.jhep.2008.12.033
doi: 10.1016/j.jhep.2008.12.033
pubmed: 19329213
Zhang Y, Chandra V, Riquelme Sanchez E, Dutta P, Quesada PR, Rakoski A et al (2020) Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med 217:e20190354. https://doi.org/10.1084/jem.20190354
Zhang Y, Ma D, Zhang Y, Tian Y, Wang X, Qiao Y et al (2011) The imbalance of Th17/Treg in patients with uterine cervical cancer. Clin Chim Acta 412:894–900. https://doi.org/10.1016/j.cca.2011.01.015
doi: 10.1016/j.cca.2011.01.015
pubmed: 21255562
Zhao L, Yang J, Wang H-P, Liu R-Y (2013) Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma. Med Oncol 30:461. https://doi.org/10.1007/s12032-013-0461-7
doi: 10.1007/s12032-013-0461-7
pubmed: 23335103
Zhong F, Cui D, Tao H, Du H, Xing C (2015) IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer. Oncology Reports 34:2365–2374. https://doi.org/10.3892/or.2015.4246
doi: 10.3892/or.2015.4246
pubmed: 26352729
Zhuang Y, Peng L-S, Zhao Y-L, Shi Y, Mao X-H, Chen W et al (2012) CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 143:951-962.e8. https://doi.org/10.1053/j.gastro.2012.06.010
doi: 10.1053/j.gastro.2012.06.010
pubmed: 22710190